Reuters Stock Buzz Powered by SocialPicks Logo_divider Logo_thomsonreuters Bg_dots_d1
   Sign Up   |   Log In   |   What is Reuters Stock Buzz?   |   FAQ powered by Logo_powered_by_socialpicks

Important Message: The Reuters Stock Buzz beta period will end Friday, October 31. If you would like to continue to access your Stock Buzz account through SocialPicks, please click here

 Cell Genesys Inc.  (CEGE)     Rate CEGE  -  Discuss CEGE  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
This is a micro-cap stock and may be a target of manipulation. Always do your research!

SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
76.5%
Top:
0.0%
Rate CEGE:



CEGE: Bull or Bear?

Foto
-4.25%
 risk: low
Bullish on CEGE ...  08/29/08
Cell Genesys, Inc., a biotechnology company, engages in the development and commercialization of biological therapies for patients with cancer. It develops cell-based cancer immunotherapies and oncolytic virus therapies. The company's GVAX cancer Immunotherapies comprise Prostate Cancer, a phase III product for the treatment of prostate cancer; Pancreatic Cancer, a phase II product for pancreatic c...




People Bullish on CEGE

Foto
Marian Filo
Principal
70%
about 1 mo ago

nmccauley
Analyst
43%
about 1 mo ago

streetlight
Analyst
N/A
2 mos ago

drgecko
Analyst
51%
3 mos ago

ribbit4u2000
Analyst
N/A
3 mos ago


People Bearish on CEGE

mluu1179
Analyst
86%
about 1 year ago

 


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Cell Genesys Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters